Bioventus
Quarterly Financials
| Values in thousands | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
|---|---|---|---|---|
Revenue | $142,442 | $153,208 | $132,089 | $157,900 |
Gross Profit | 97,128 | 105,666 | 89,662 | 107,485 |
EBITDA | 10,092 | 30,321 | 20,048 | 31,143 |
EBIT | 9,044 | 19,376 | 8,843 | 19,449 |
Net Income | 5,987 | 33,441 | 3,113 | 14,755 |
Net Change In Cash | 142,442 | 153,208 | 132,089 | 157,900 |
Free Cash Flow | 20,324 | 18,913 | 8,359 | 37,388 |
Cash | 30,709 | 29,457 | 35,846 | 51,238 |
Basic Shares | 72,493 | 70,838 | 70,008 | 68,914 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $568,087 | $573,280 | $512,345 | $512,117 |
Gross Profit | 382,430 | 388,226 | 328,193 | 331,080 |
EBITDA | 99,206 | 39,221 | -23,070 | -121,606 |
EBIT | 52,195 | -10,334 | -80,435 | -177,004 |
Net Income | 22,732 | -33,542 | -156,230 | -158,704 |
Net Change In Cash | 568,087 | 573,280 | 512,345 | 512,117 |
Free Cash Flow | 71,414 | 37,789 | 7,982 | -15,015 |
Cash | 51,238 | 41,582 | 36,964 | 30,186 |
Basic Shares | 68,914 | 65,355 | 62,647 | 61,389 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-09-30 | $0.17 |
2026-06-30 | $0.22 |
2026-03-31 | $0.15 |
2025-12-31 | $0.24 |